Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4782-4791

  Bruner Tran, Kaylon L ^a   Eisenberg, Esther ^a   Yeaman, Grant R ^b   Anderson, Ted A ^a   McBean, Judith ^a   Osteen, Kevin G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROGESTERONE; RETINOIC ACID; STEROID; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION REGULATION; HORMONE RESISTANCE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SECRETION;

ADOLESCENT; ADULT; ANIMALS; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PROGESTERONE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

MUS MUSCULUS;

EID: 0036775117     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020418     Document Type: Article

References (77)

1. Curry Jr TE, Osteen KG 2001 Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 64:1285-1296
2. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F 1993 Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168:253-260
3. Rodgers WH, Matrisian LM, Giudice LC, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG 1994 Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94:946-953
4. Maatta M, Soini Y, Liakka A, Autio-Harmainen H 2000 Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 114:402-411
5. Singer CF, Marbaix E, Lemoine P, Courtoy PJ, Eeckhout Y 1999 Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 259:40-45
6. Keller NR, Sierra-Rivera E, Eisenberg E, Osteen KG 2000 Progesterone exposure prevents matrix metalloproteinase-3 (MMT-3) stimulation by interleukin-1alpha in human endometrial stromal cells. J Clin Endocrinol Metab 85:1611-1619
7. Osteen KG, Bruner-Tran KL, Keller NR, Eisenberg E 2002 Progesterone-mediated endometrial maturation limits matrix metalloproteinase (MMP) expression in an inflammatory-like environment: A regulatory system altered in endometriosis. N Y Acad Sci 955:37-47
8. Fujii S 1991 Secondary mullerian system and endometriosis. Am J Obstet Gynecol 165:219-225
9. Ishimura T, Masuzaki H 1991 Peritoneal endometriosis: Endometrial tissue implantation as its primary etiologic mechanism. Am J Obstet Gynecol 165:210-214
10. Sampson JA 1927 Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422-469
11. Spuijbroek MD, Dunselman GA, Menheere PP, Evers JL 1992 Early endometriosis invades the extracellular matrix. Fertil Steril 58:929-933
12. Osteen KG, Bruner KL, Sharpe-Timms KL 1996 Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 14:247-255
13. Saito T, Mizumoto H, Kuroki K, Fujii M, Mori S, Kudo R 1995 [Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol]. Nippon Sanka Fujinka Gakkai Zasshi 47:495-496
14. Sharpe-Timms KL, Keisler LW, Mclntush EW, Keisler DH 1998 Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril 69:1128-1134
15. Wenzl RJ, Heinzl H 1998 Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol Obstet Invest 45:253-257
16. Gottschalk C, Malberg K, Arndt M, Schmitt J, Roessner A, Schultze D, Kleinstein J, Ansorge S 2000 Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis. Adv Exp Med Biol 477:483-486
17. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M 2001 Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness. Fertil Steril 75:152-159
18. Bruner-Tran KL, Webster-Clair D, Osteen KG 2002 Experimental endometriosis: The nude mouse as a xenographic host. N Y Acad Sci 955:328-339
19. Halme J, Stovall D 1995 Endometriosis and its medical management. In: Wallach EE, Zacur HA, eds. Reproductive Surgery and Medicine. St. Louis: Mosby; 695-710
20. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Zhou J, Sebastian S 2001 Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol 79:19-25
21. Ramzy I 1989 Pathology. In: Schenken RS, ed. Endometriosis: Contemporary Concepts and Clinical Management. Philadelphia: JB Lippincott; 60
22. Olive DL 1989 Medical treatment: Alternatives to danazol. In: Schenken RS, ed. Endometriosis: Contemporary Concepts and Clinical Management. Philadelphia: JB Lippincott; 192
23. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG 1997 Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 99:2851-2857
24. Lessey BA, Metzger DA, Haney AF, McCarty KS, Jr. 1989 Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: Comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 51:409-415
25. Bergqvist A, Ferno M 1993 Oestrogen and progesterone receptors in endometriotic tissue and endometrium: Comparison of different cycle phases and ages. Hum Reprod 8:2211-2217
26. Misao R, Iwagaki S, Fujimoto J, Sun W, Tamaya T 1999 Dominant expression of progesterone receptor form B mRNA in ovarian endometriosis. Horm Res 52:30-34
27. Noble LS, Simpson ER, Johns A, Bulun SE 1996 Aromatase expression in endometriosis. J Clin Endocrinol Metab 81:174-179
28. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE 1998 Deficient 17β-hydroxy-steroid dehydrogenase type 2 expression in endometriosis: Failure to metabolize 17β-estradiol. J Clin Endocrinol Metab 83:4474-4480
29. Giudice LC 1994 Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine. Fertil Steril 61:1-17
30. Tabibzadeh S, Sun XZ 1992 Cytokine expression in human endometrium throughout the menstrual cycle. Hum Reprod 7:1214-1221
31. Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM, Osteen KG 1995 Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 92:7362-7366
32. Bruner KL, Ong DE, Eisenberg E, Osteen KG 1999 Progesterone regulation of endometrial MMP-3 expression requires the cooperative action of transforming growth factor-β and retinoic acid. Biol Reprod 60(Suppl 1):272
33. Zheng WL, Sierra-Rivera E, Luan J, Osteen KG, Ong DE 2000 Retinoic acid synthesis and expression of cellular retinol-binding protein and cellular retinoic acid-binding protein type II are concurrent with decidualization of rat uterine stromal cells. Endocrinology 141:802-808
34. Osteen KG, Bruner-Tran KL, Ong D, Eisenberg E 2002 Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis. Ann N Y Acad Sci 955:139-146; discussion 157-158, 396-406
35. Bruner KL, Eisenberg E, Gorstein F, Osteen KG 1999 Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 64:648-653
36. Bruner KL, Derfoul A, Robertson NM, Guerriero G, Fernandes-Alnemri T, Alnemri ES, Litwack G 1997 The unliganded mineralocorticoid receptor is associated with heat shock proteins 70 and 90 and the immunophilin FKBP-52. Recept Signal Transduct 7:85-98
37. Cox KH, DeLeon DV, Angerer LM, Angerer RC 1984 Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101:485-502
38. Motulsky HJ 1999 Analyzing Data with GraphPad Prism. San Diego, CA: GraphPad Software Inc.
39. Olive DL, Pritts EA 2001 Treatment of endometriosis. N Engl J Med 345:266-275
40. Rice VM 2002 Conventional medical therapies for endometriosis. Ann N Y Acad Sci 955:343-352
41. D'Hooghe TM, Bambra CS, De Jonge I, Lauweryns JM, Raeymaekers BM, Koninckx PR 1997 The effect of pregnancy on endometriosis in baboons (Papio anubis, Papio cynocephalus). Arch Gynecol Obstet 261:15-19
42. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS 1992 Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662
43. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM 1994 Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 91:10129-10133
44. Schatz F, Papp C, Toth-Pal E, Lockwood CJ 1994 Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J Clin Endocrinol Metab 78:1467-1472
45. Simon C, Valbuena D, Krussel J, Bernal A, Murphy CR, Shaw T, Pellicer A, Polan ML 1998 Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium Fertil Steril 70:896-906
46. Lessey BA, Yeh I, Castelbaum AJ, Fritz MA, Ilesanmi AO, Korzeniowski P, Sun J, Chwalisz K 1996 Endometrial progesterone receptors and markers of uterine receptivity in the window of implantation. Fertil Steril 65:477-483
47. Tseng JF, Ryan IP, Milam TD, Murai JT, Schriock ED, Landers DV, Taylor RN 1996 Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 81:1118-1122
48. Wegner EL, McBean JH, Khavari A, Brumsted JR, Abnormal MMP-3 expression in the endometrium of women with endometriosis. Proc 52nd Annual Meeting of the American Society of Reproductive Medicine, Boston, MA, 1996 (Abstract 323)
49. Eyster KM, Boles AL, Brannian JD, Hansen KA 2002 DNA microarray analysis of gene expression markers of endometriosis. Fertil Steril 77:38-42
50. Sillem M, Hahn U, Coddington 3rd CC, Gordon K, Runnebaum B, Hodgen GD 1996 Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey (Macaca fascicularis) model of endometriosis. Fertil Steril 66:468-473
51. Bruner KL, Keller NK, Osteen KG 1998 Interleukin 1a opposes suppression of human endometrial matrix metalloproteinases by progesterone in a model of experimental endometriosis. In: Lemay A, Maheux R, eds. Understanding and Managing Endometriosis: Advances in Research and Practice. New York: Parthenon Publishing
52. Uria JA, Stahle-Backdahl M, Seiki M, Fueyo A, Lopez-Otin C 1997 Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 57:4882-4888
53. Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, Hirtenlehner K, Seifert M, Kubista E 2002 MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat 72:69-77
54. Ko K, Yazumi S, Yoshikawa K, Konda Y, Nakajima M, Chiba T, Takahashi R 2000 Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact Co-cultures. Int J Cancer 87:165-171
55. Ace CI, Okulicz WC 1995 Differential gene regulation by estrogen and progesterone in the primate endometrium. Mol Cell Endocrinol 115:95-103
56. Sachdeva G, Patil V, Katkam RR, Manjramkar DD, Kholkute SD, Puri CP 2001 Expression profiles of endometrial leukemia inhibitory factor, transforming growth factor β2 (TGFβ2), and TGFβ2 receptor in infertile bonnet monkeys. Biol Reprod 65:1-8
57. Li TC, Spuijbroek MD, Tuckerman E, Anstie B, Loxley M, Laird S 2000 Endocrinological and endometrial factors in recurrent miscarriage. BJOG 107:1471-1479
58. Lea RG, Underwood J, Flanders KC, Hirte H, Banwatt D, Finotto S, Ohno I, Daya S, Harley C, Michel M, Daya S, Harley C, Mowbray JF, Clark DA 1995 A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor β-2-producing "suppressor cells" in uterine tissue near the placental attachment site. Am J Reprod Immunol 34:52-64
59. Gorivodsky M, Torchinsky A, Zemliak I, Savion S, Fein A, Toder V 1999 TGF β 2 mRNA expression and pregnancy failure in mice. Am J Reprod Immunol 42:124-133
60. Kothapalli R, Buyuksal I, Wu SQ, Chegini N, Tabibzadeh S 1997 Detection of ebaf, a novel human gene of the transforming growth factor β superfamily association of gene expression with endometrial bleeding. J Clin Invest 99:2342-2350
61. Cornet PB, Picquet C, Lemoine P, Osteen KG, Bruner-Tran KL, Tabibzadeh S, Courtoy PJ, Eeckout Y, Marbaix E, Henriet P, Regulation and function of LEFTY/EBAF in the human endometrium: mRNA expression during the menstrual cycle, control by progesterone and effect on matrix metalloproteinases. J Biol Chem, in press
62. Tabibzadeh S, Mason JM, Shea W, Cai Y, Murray MJ, Lessey B 2000 Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab 85:2526-2536
63. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV 1985 Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705
64. Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ 1995 Induction of transforming growth factor β 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res 55:2380-2386
65. Creek KE, Geslani G, Batova A, Pirisi L 1995 Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-β at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes. Adv Exp Med Biol 375:117-135
66. Falk LA, De Benedetti F, Lohrey N, Birchenall-Roberts MC, Ellingsworth LW, Faltynek CR, Ruscetti FW 1991 Induction of transforming growth factor-β 1 (TGF-β1), receptor expression and TGF-β 1 protein production in retinoic acid-treated HL-60 cells: Possible TGF-β 1-mediated autocrine inhibition. Blood 77:1248-1255
67. Glick AB, Flanders KC, Danielpour D, Yuspa SH, Sporn MB 1989 Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul 1:87-97
68. Underwood BA 1984 Vitamin A in animal and human nutrition. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids. London: Academic Press
69. Simsek M, Naziroglu M, Simsek H, Cay M, Aksakal M, Kumru S 1998 Blood plasma levels of lipoperoxides, glutathione peroxidase, β carotene, vitamin A and E in women with habitual abortion. Cell Biochem Funct 16:227-231
70. Tarrade A, Rochette-Egly C, Guibourdenche J, Evain-Brion D 2000 The expression of nuclear retinoid receptors in human implantation. Placenta 21:703-710
71. Wilson J, Roth CB, Warkany J 1953 An analysis of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 92:189-217
72. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T 1997 TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 124:2659-2670
73. O'Toole BA, Fradkin R, Warkany J, Wilson JG, Mann GV 1974 Vitamin A deficiency and reproduction in rhesus monkeys. J Nutr 104:1513-1524
74. Salamonsen LA, Kovacs GT, Findlay JK 1999 Current concepts of the mechanisms of menstruation. Baillieres Best Pract Res Clin Obstet Gynaecol 13:161-179
75. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, Osteen K, Taylor RN, Lessey BA, Giudice LC 2002 Global gene profiling in human endometrium during the window of implantation. Endocrinology 143:2119-2138
76. Giudice LC, Telles TL, Lobo S, Kao L 2002 The molecular basis for implantation failure in endometriosis: On the road to discovery. Ann N Y Acad Sci 955:252-64; discussion 293-295, 396-406
77. Bruner-Tran KL, Rier SE, Eisenberg E, Osteen KG 1999 The potential role of environmental toxins in the pathophysiology of endometriosis. Gynecol Obstet Invest 48(Suppl 1):45-56